Literature DB >> 28276592

Low Serum DHEAS Predicts Increased Fracture Risk in Older Men: The MrOS Sweden Study.

Claes Ohlsson1, Maria Nethander2, Andreas Kindmark3, Östen Ljunggren3, Mattias Lorentzon1,4, Björn E Rosengren5, Magnus K Karlsson5, Dan Mellström1,4, Liesbeth Vandenput1.   

Abstract

The adrenal-derived hormones dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) are the most abundant circulating hormones and their levels decline substantially with age. DHEAS is considered an inactive precursor, which is converted into androgens and estrogens via local metabolism in peripheral target tissues. The predictive value of serum DHEAS for fracture risk is unknown. The aim of this study was, therefore, to assess the associations between baseline DHEAS levels and incident fractures in a large cohort of older men. Serum DHEAS levels were analyzed with mass spectrometry in the population-based Osteoporotic Fractures in Men study in Sweden (n = 2568, aged 69 to 81 years). Incident X-ray validated fractures (all, n = 594; non-vertebral major osteoporotic, n = 255; hip, n = 175; clinical vertebral, n = 206) were ascertained during a median follow-up of 10.6 years. DHEAS levels were inversely associated with the risk of any fracture (hazard ratio [HR] per SD decrease = 1.14, 95% confidence interval [CI] 1.05-1.24), non-vertebral major osteoporotic fractures (HR = 1.31, 95% CI 1.16-1.48), and hip fractures (HR = 1.18, 95% CI 1.02-1.37) but not clinical vertebral fractures (HR = 1.09, 95% CI 0.95-1.26) in Cox regression models adjusted for age, body mass index (BMI) and prevalent fractures. Further adjustment for traditional risk factors for fracture, bone mineral density (BMD), and/or physical performance variables as well as serum sex steroid levels only slightly attenuated the associations between serum DHEAS and fracture risk. Similarly, the point estimates were only marginally reduced after adjustment for FRAX estimates with BMD. The inverse association between serum DHEAS and all fractures or major osteoporotic fractures was nonlinear, with a substantial increase in fracture risk (all fractures 22%, major osteoporotic fractures 33%) for those participants with serum DHEAS levels below the median (0.60 μg/mL). In conclusion, low serum DHEAS levels are a risk marker of mainly non-vertebral fractures in older men, of whom those with DHEAS levels below 0.60 μg/mL are at highest risk.
© The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals Inc. © The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals Inc.

Entities:  

Keywords:  DHEAS; FRACTURE RISK ASSESSMENT; GENERAL POPULATION STUDIES; MEN; SEX STEROIDS

Mesh:

Substances:

Year:  2017        PMID: 28276592     DOI: 10.1002/jbmr.3123

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  4 in total

1.  Importance of Dehydroepiandrosterone Sulfate Assessment with Special Attention for Adrenal Tumours and Arterial Hypertension.

Authors:  V Matulevicius; V Urbanavicius; S Lukosevicius; I Banisauskaite; G Donielaite; A Galkine
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

2.  Improved prediction of fracture risk leveraging a genome-wide polygenic risk score.

Authors:  Tianyuan Lu; Vincenzo Forgetta; Julyan Keller-Baruch; Maria Nethander; Derrick Bennett; Marie Forest; Sahir Bhatnagar; Robin G Walters; Kuang Lin; Zhengming Chen; Liming Li; Magnus Karlsson; Dan Mellström; Eric Orwoll; Eugene V McCloskey; John A Kanis; William D Leslie; Robert J Clarke; Claes Ohlsson; Celia M T Greenwood; J Brent Richards
Journal:  Genome Med       Date:  2021-02-03       Impact factor: 11.117

3.  Sex hormones and quantitative ultrasound parameters at the heel in men and women from the general population.

Authors:  Konrad Pätzug; Nele Friedrich; Hanna Kische; Anke Hannemann; Henry Völzke; Matthias Nauck; Brian G Keevil; Robin Haring
Journal:  Bone Rep       Date:  2017-08-18

4.  Increased risk for hip fracture after death of a spouse-further support for bereavement frailty?

Authors:  C H Vala; M Lorentzon; V Sundh; H Johansson; C Lewerin; S Sten; M Karlsson; C Ohlsson; B Johansson; J A Kanis; D Mellström
Journal:  Osteoporos Int       Date:  2019-12-12       Impact factor: 4.507

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.